Join the 200th Anniversary Celebration

Special Report

Survival after the Age of 80 in the United States, Sweden, France, England, and Japan

Kenneth G. Manton, Ph.D., and James W. Vaupel, Ph.D.

N Engl J Med 1995; 333:1232-1235November 2, 1995

Abstract

Background

In many developed countries, life expectancy at birth is higher than in the United States. Newly available data permit, for the first time, reliable cross-national comparisons of mortality among persons 80 years of age or older. Such comparisons are important, because in many developed countries more than half of women and a third of men now die after the age of 80.

Methods

We used extinct-cohort methods to assess mortality in Japan, Sweden, France, and England (including Wales) and among U.S. whites for cohorts born from 1880 to 1894, and used cross-sectional data for the year 1987. Extinct-cohort methods rely on continuously collected data from death certificates and do not use the less reliable data from censuses.

Results

In the United States, life expectancy at the age of 80 and survival from the ages of 80 to 100 significantly exceeded life expectancy in Sweden, France, England, and Japan (P<0.01). This finding was confirmed with accurate cross-sectional data for 1987. The average life expectancy in the United States is 9.1 years for 80-year-old white women and 7.0 years for 80-year-old white men.

Conclusions

For people 80 years old or older, life expectancy is greater in the United States than it is in Sweden, France, England, or Japan.

Media in This Article

Figure 1Probability of Survival after the Age of 80 among U.S. Whites and Japanese, Swedish, French, and English and Welsh Persons Born from 1885 to 1889.
Table 1Five-Year Survival at Various Ages and Life Expectancy at 80 for U.S. Whites and for Japan, Sweden, France, and England for Cohorts Born in 1880–1884, 1885–1889, and 1890–1894 and for the Year 1987.
Article

Americans under the age of 65 have a higher mortality rate than the citizens of many European countries and Japan.1 Between the ages of 65 and 80 the differences in mortality diminish. Until recently, lack of data precluded reliable comparisons at later ages. New data now permit comparisons among people 80 to 100 years old.2-4 This is important, because survival to the age of 80 and beyond has increased in many developed countries.2-7 Largely because of reductions in mortality, the number of people over the age of 80 — who are high per capita users of health services — is growing rapidly.2-4,8,9 We compared the survival of persons 80 or older in the United States with that in four other developed countries, using the most reliable data available.

Methods

We calculated death rates using age-specific numbers of deaths and numbers of people at risk. Age reporting is generally less accurate in periodic censuses than on continuously collected death certificates. By summing deaths from those of the oldest persons backward to estimate age-specific population sizes, we could calculate cohort life tables solely from mortality data.2,10 This “extinct cohort” method was used to estimate survival at 80 and older in Japan, Sweden, France, and England (including Wales).2,3 The same method was applied to all U.S. death certificates filed between 1962 and 1990 for white men and women 80 or older who were born from 1880 through 1894.

The accuracy of U.S. death rates for those over 80 has been questioned.5 Research suggests that published mortality rates are reasonably reliable for U.S. whites up to the age of 100.5,11 The reliability of death rates for U.S blacks is less certain,12 although recent studies of mortality10 and Medicare13 data have confirmed the lower mortality among blacks than whites over the age of 85 that has been reported in vital-statistics data. Factors that have improved the reporting of ages on U.S. death certificates include the completion of the vital-registration, Medicare, and Social Security systems and their computerization, along with rising educational levels among the elderly.11,14,15

U.S. death rates in 1987 have been calculated for Medicare Part B enrollees.13 Because Part B coverage is purchased with monthly premiums, the data are of high quality. We compared these rates with Japanese, Swedish, French, and English rates for 1987.

Results

Life expectancies at the age of 80 and five-year survival probabilities at the ages of 80, 85, 90, and 95 are shown in Table 1Table 1Five-Year Survival at Various Ages and Life Expectancy at 80 for U.S. Whites and for Japan, Sweden, France, and England for Cohorts Born in 1880–1884, 1885–1889, and 1890–1894 and for the Year 1987. for the 1880–1894 birth cohorts and for 1987 for the United States, Japan, Sweden, France, and England. Life expectancy and survival are significantly better for these cohorts in the United States than in the other countries at all ages and for both sexes (P<0.01). In all the countries, life expectancy at the age of 80 increased from the 1880–1884 cohort to the 1890–1894 cohort. In 1987 only the survival of Japanese 80-year-old men exceeded that of comparable U.S. men (P not significant).

Figure 1Figure 1Probability of Survival after the Age of 80 among U.S. Whites and Japanese, Swedish, French, and English and Welsh Persons Born from 1885 to 1889. shows survival curves for persons 80 to 100 years of age in the 1885–1889 birth cohort. The United States had the best survival, and Japan the worst. Whereas half of 80-year-old U.S. men survived to the age of 86, half of Japanese men survived only to the age of 84.5. For women, median survival was two years longer in the United States than in Japan.

Discussion

As compared with mortality in Sweden, France, England, and Japan, mortality in the United States is relatively high before the age of 65 and relatively low at the age of 80 and after. Possible reasons include both current health-related policies and conditions and lingering cohort effects of earlier conditions.

Greater heterogeneity in social and economic status and health insurance coverage in the United States may account for much of the disadvantage at younger ages in this country.16-19 Medicare, Medicaid, and Social Security reduce this heterogeneity at older ages. Whereas 84.3 percent of Americans under 65 had health insurance in 1991,20 98.4 percent of the elderly had Medicare coverage.21 Reduced survival of disadvantaged groups also decreases heterogeneity at older ages.

More than in Japan or Europe, the elderly in the United States may demand high-quality health services and may modify their behavior to limit their risk factors. More rapid reductions in cholesterol levels, hypertension, and smoking in the United States may reflect this.22-26

In the United States, elderly patients may receive more effective medical care than elderly patients in Japan or Europe. The United States devoted 12.4 percent of its gross national product to health care in 1990, as compared with 5 to 8 percent in Japan and Europe, where cost control produces de facto rationing of health care for the elderly.27 Japan, with the world's highest life expectancy at birth (76.2 years for boys and 83.0 years for girls) and a rapidly aging population, spent only 6 percent of its gross national product on health care in 1990. Copayments impede access to care and increase rates of illness among elderly Japanese with low incomes. Shortages of long-term care facilities and rehabilitation services also adversely affect the health of elderly Japanese. In 1987, 29 percent of hospital stays were for more than six months; the majority of these hospitalized patients were elderly (69 percent), many of them (40 percent) with strokes.28 In Denmark, where health care spending is limited to 5.9 percent of the gross national product, there are 6-to-12-month waits for cataract and hip surgery. The wait for cardiac procedures exceeds three months. The effects of such delays are not benign for persons who are 80 or older.

Four persistent cohort effects may also be important. First, the well-educated tend to be relatively healthy. Elderly people in the United States may be better educated than those in Europe or Japan.14 Second, immigrants may be healthier than the contemporaries they left behind.29 Descendants of immigrants may also be relatively healthy. Many elderly people in the United States are either immigrants or the children of immigrants. Third, high mortality at younger ages may leave a select group of robust survivors at advanced ages. This may contribute to the U.S. advantage over Sweden at older ages.30 Fourth, adverse health conditions at younger ages may increase impairment among the survivors and elevate subsequent mortality rates.31 The relatively high mortality at older ages in Japan could be a legacy of poor health conditions before the 1950s. Because few severely debilitated people will survive into their 80s, however, this effect may be less important at advanced ages.32

The plausibility of most of these explanations depends on whether medical care and personal behavior can substantially improve health among the very old. Health changes once accepted as normal features of aging (e.g., frailty and senility) are now viewed as age-related diseases (e.g., osteoporosis and the dementias).8,9 New estimates of the age-related loss of physiologic functions are lower than earlier ones.33 Decreases in mortality in recent decades and differences in survival between subpopulations suggest that medical and public health interventions substantially affect survival at older ages.2-4,8,9,34

Increasing longevity may not raise costs disproportionately.35 In 1989–1990, the Medicare cost for those who died at the age of 70 was $6,457 in each of the last five years of life. The corresponding cost for those who survived to 100 was $1,800 per year, because their costs, both in and before the final year of life, were low. Cost-effective therapies are emerging, including antibiotics for ulcers,36 exogenous estrogen for postmenopausal women,37,38 angiotensin-converting–enzyme inhibitors,39 and geriatric-evaluation units.40

The U.S. success in increasing survival after the age of 80 was neglected in the debates over health care reform in this country. To understand the strengths and weaknesses of the U.S. system, it is important to consider the causes of success at older ages as well as the problems at younger ages.

Supported by grants from the National Institute on Aging (AG08761 and AG01159) and the Danish Research Council.

We are indebted to Kirill Andreev, who did the programming for the life-table and standard-error calculations.

Source Information

From the Center for Demographic Studies (K.G.M.) and the Sanford Institute of Public Policy (J.W.V.), Duke University, Durham, N.C.; and Odense University Medical School, Odense, Denmark (J.W.V.).

Address reprint requests to Dr. Manton at Duke University, Center for Demographic Studies, 2117 Campus Dr., Box 90408, Durham, NC 27708-0408.

References

References

  1. 1

    World health statistics annual, 1993. Geneva: World Health Organization, 1994.

  2. 2

    Kannisto AU. Development of oldest-old mortality, 1950-1990: evidence from 28 developed countries. Odense, Denmark: Odense University Press, 1994.

  3. 3

    Kannisto V, Lauritsen J, Thatcher AR, Vaupel JW. Reductions in mortality at advanced ages: several decades of evidence from 27 countries. Popul Dev Rev 1994;20:793-810
    CrossRef | Web of Science

  4. 4

    Vaupel JW, Jeune B. The emergence and proliferation of centenarians. In: Jeune B, Vaupel JW, eds. Exceptional longevity. Odense, Denmark: Odense University Press, 1995.

  5. 5

    Condran GA, Himes CL, Preston SH. Old age mortality patterns in low-mortality countries: an evaluation of population and death data at advanced ages, 1950 to the present. Popul Bull U N 1991;30:23-61

  6. 6

    Life tables for the United States Social Security Area 1900-2080. Actuarial study no. 107. Baltimore: Social Security Administration, 1992. (SSA publication no. 11-11536.)

  7. 7

    Bureau of the Census, Day JC. Population projections of the United States, by age, sex, race, and Hispanic origin: 1993 to 2050. Current population reports. Series P25-1104. Washington, D.C.: Government Printing Office, 1993.

  8. 8

    Campion EW. The oldest old. N Engl J Med 1994;330:1819-1820
    Full Text | Web of Science | Medline

  9. 9

    Suzman RM, Willis DP, Manton KG, eds. The oldest old. New York: Oxford University Press, 1992.

  10. 10

    Manton KG, Stallard E. Ethnic health and disability differences in the U.S. elderly population. Presented at the Workshop on Racial and Ethnic Differences in Health in Late Life, Washington, D.C., December 12–13, 1994. abstract.

  11. 11

    Rosenwaike I, Logue B. The extreme aged in America: a portrait of an expanding population. Westport, Conn.: Greenwood Press, 1985.

  12. 12

    Elo IT, Preston SH. Estimating African-American mortality from inaccurate data. Demography 1994;31:427-458
    CrossRef | Web of Science | Medline

  13. 13

    Kestenbaum B. A description of the extreme aged population based on improved Medicare enrollment data. Demography 1992;29:565-580
    CrossRef | Web of Science | Medline

  14. 14

    Preston SH. Demographic change in the United States, 1970-2050. In: Manton K, Singer B, Suzman R, eds. Forecasting the health of elderly populations. New York: Springer-Verlag, 1992:51-78.

  15. 15

    Bayo FR, Faber JF. Mortality rates around age one hundred. Trans Soc Actuaries 1985;35:37-59

  16. 16

    Morris JK, Cook DG, Shaper AG. Loss of employment and mortality. BMJ 1994;308:1135-1139
    CrossRef | Web of Science | Medline

  17. 17

    Pappas G, Queen S, Hadden W, Fisher G. The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986. N Engl J Med 1993;329:103-109
    Full Text | Web of Science | Medline

  18. 18

    Adler NE, Boyce T, Chesney MA, et al. Socioeconomic status and health: the challenge of the gradient. Am Psychol 1994;49:15-24
    CrossRef | Web of Science | Medline

  19. 19

    Franks P, Clancy CM, Gold MR. Health insurance and mortality: evidence from a national cohort. JAMA 1993;270:737-741
    CrossRef | Web of Science | Medline

  20. 20

    Swartz K. Dynamics of people without health insurance: don't let the numbers fool you. JAMA 1994;271:64-66
    CrossRef | Web of Science | Medline

  21. 21

    Bureau of the Census. Statistical abstract of the United States, 1993. 113th ed. Washington, D.C.: Government Printing Office, 1993.

  22. 22

    Sempos CT, Cleeman JI, Carroll MD, et al. Prevalence of high blood cholesterol among US adults: an update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel. JAMA 1993;269:3009-3014
    CrossRef | Web of Science | Medline

  23. 23

    Johnson CL, Rifkind BM, Sempos CT, et al. Declining serum total cholesterol levels among US adults: the national health and nutrition examination surveys. JAMA 1993;269:3002-3008
    CrossRef | Web of Science | Medline

  24. 24

    Verschuren WM, Boerma GJ, Kromhout D. Total and HDL-cholesterol in The Netherlands: 1987-1992: levels and changes over time in relation to age, gender and educational level. Int J Epidemiol 1994;23:948-956
    CrossRef | Web of Science | Medline

  25. 25

    Hoffmeister H, Mensink GB, Stolzenberg H. National trends in risk factors for cardiovascular disease in Germany. Prev Med 1994;23:197-205
    CrossRef | Web of Science | Medline

  26. 26

    National Center for Health Statistics. Health, United States, 1993. Washington, D.C.: Government Printing Office, 1994. (DHHS publication no. (PHS) 94-1232.)

  27. 27

    Dixon J. US health care. II. The cost problem. BMJ 1992;305:878-880
    CrossRef | Web of Science | Medline

  28. 28

    Okamoto Y. Health care for the elderly in Japan: medicine and welfare in an aging society facing a crisis in long term care. BMJ 1992;305:403-405
    CrossRef | Web of Science | Medline

  29. 29

    Sorlie PD, Backlund E, Johnson NJ, Rogot E. Mortality by Hispanic status in the United States. JAMA 1993;270:2464-2468
    CrossRef | Web of Science | Medline

  30. 30

    Manton KG, Stallard E, Vaupel JW. Alternative models for the heterogeneity of mortality risks among the aged. J Am Stat Assoc 1986;81:635-644
    CrossRef | Web of Science | Medline

  31. 31

    Elo IT, Preston SH. Effects of early-life conditions on adult mortality: a review. Popul Index 1992;58:186-212
    CrossRef | Medline

  32. 32

    Manton KG, Stallard E, Woodbury MA, Dowd JE. Time-varying covariates in models of human mortality and aging: multidimensional generalizations of the Gompertz. J Gerontol 1994;49:B169-B190
    Medline

  33. 33

    Kasch FW, Boyer JL, Van Camp SP, Verity LS, Wallace JP. Effect of exercise on cardiovascular ageing. Age Ageing 1993;22:5-10
    CrossRef | Web of Science | Medline

  34. 34

    Manton KG, Stallard E, Tolley HD. Limits to human life expectancy: evidence, prospects, and implications. Popul Dev Rev 1991;17:603-637
    CrossRef | Web of Science

  35. 35

    Lubitz J, Beebe J, Baker C. Longevity and Medicare expenditures. N Engl J Med 1995;332:999-1003
    Full Text | Web of Science | Medline

  36. 36

    Hentschel E, Brandstatter G, Dragosics B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993;328:308-312
    Full Text | Web of Science | Medline

  37. 37

    Nabulsi AA, Folsom AR, White A, et al. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 1993;328:1069-1075
    Full Text | Web of Science | Medline

  38. 38

    Bellantoni MF, Harman SM, Cullins VE, Engelhardt SM, Blackman MR. Transdermal estradiol with oral progestin: biological and clinical effects in younger and older postmenopausal women. J Gerontol 1991;46:M216-M222
    Medline

  39. 39

    Paul SD, Kuntz KM, Eagle KA, Weinstein MC. Costs and effectiveness of angiotensin converting enzyme inhibition in patients with congestive heart failure. Arch Intern Med 1994;154:1143-1149
    CrossRef | Web of Science | Medline

  40. 40

    Landefeld CS, Palmer RM, Kresevic DM, Fortinsky RH, Kowat J. A randomized trial of care in a hospital medical unit especially designed to improve the functional outcomes of acutely ill older patients. N Engl J Med 1995;332:1338-1344
    Full Text | Web of Science | Medline

Citing Articles (69)

Citing Articles

  1. 1

    W. Jack Rejeski, Jonathan Burdette, Marley Burns, Ashley R. Morgan, Satoru Hayasaka, James Norris, Donald Williamson, Paul J. Laurienti. (2012) Power of Food ModeratesFood Craving, Perceived Control, and Brain Networks Following a Short-Term Post-Absorptive State in Older Adults. Appetite
    CrossRef

  2. 2

    Katharina M. Busl, Raul G. Nogueira, Albert J. Yoo, Joshua A. Hirsch, Lee H. Schwamm, Natalia S. Rost. (2011) Prestroke Dementia is Associated with Poor Outcomes after Reperfusion Therapy among Elderly Stroke Patients. Journal of Stroke and Cerebrovascular Diseases
    CrossRef

  3. 3

    R. A. Fielding, W. J. Rejeski, S. Blair, T. Church, M. A. Espeland, T. M. Gill, J. M. Guralnik, F.-C. Hsu, J. Katula, A. C. King, S. B. Kritchevsky, M. M. McDermott, M. E. Miller, S. Nayfield, A. B. Newman, J. D. Williamson, D. Bonds, S. Romashkan, E. Hadley, M. Pahor, . (2011) The Lifestyle Interventions and Independence for Elders Study: Design and Methods. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 66A:11, 1226-1237
    CrossRef

  4. 4

    Young Joon Hong, Myung Ho Jeong, Alexander Abizaid, Adrian Banning, Antonio Bartorelli, Vladimir Dzavik, Stephen G. Ellis, Runlin Gao, David R. Holmes, Victor Legrand, Franz-Josef Neumann, Christian Spaulding, Stephen Worthley, Philip Urban. (2011) Sirolimus-Eluting Coronary Stents in Octogenarians. JACC: Cardiovascular Interventions 4:9, 982-991
    CrossRef

  5. 5

    Rasmus Hoffmann. (2011) Socioeconomic inequalities in old-age mortality: A comparison of Denmark and the USA. Social Science & Medicine 72:12, 1986-1992
    CrossRef

  6. 6

    Jessica Y. Ho, Samuel H. Preston. (2010) US Mortality in an International Context: Age Variations. Population and Development Review 36:4, 749-773
    CrossRef

  7. 7

    Adeel Safdar, Justin deBeer, Mark A. Tarnopolsky. (2010) Dysfunctional Nrf2–Keap1 redox signaling in skeletal muscle of the sedentary old. Free Radical Biology and Medicine 49:10, 1487-1493
    CrossRef

  8. 8

    Francesco Landi, Angela M. Abbatecola, Mauro Provinciali, Andrea Corsonello, Silvia Bustacchini, Luca Manigrasso, Antonio Cherubini, Roberto Bernabei, Fabrizia Lattanzio. (2010) Moving against frailty: does physical activity matter?. Biogerontology 11:5, 537-545
    CrossRef

  9. 9

    Kae Okuma, Hideomi Yamashita, Kei Kawana, Shunsuke Nakagawa, Katsutoshi Oda, Keiichi Nakagawa. (2010) Advanced age is a significant determinant of poor prognosis in patients treated with surgery plus postoperative radiotherapy for endometrial cancer. Journal of Obstetrics and Gynaecology Research 36:4, 757-763
    CrossRef

  10. 10

    Steven G. Coca. (2010) Acute Kidney Injury in Elderly Persons. American Journal of Kidney Diseases 56:1, 122-131
    CrossRef

  11. 11

    Kaare Christensen, Gabriele Doblhammer, Roland Rau, James W Vaupel. (2009) Ageing populations: the challenges ahead. The Lancet 374:9696, 1196-1208
    CrossRef

  12. 12

    Magdalena M. Muszyńska, Roland Rau. (2009) Falling Short of Highest Life Expectancy: How Many Americans Might Have Been Alive in the Twentieth Century?. Population and Development Review 35:3, 585-603
    CrossRef

  13. 13

    W. J. Rejeski, A. P. Marsh, E. Chmelo, A. J. Prescott, M. Dobrosielski, M. P. Walkup, M. Espeland, M. E. Miller, S. Kritchevsky. (2009) The Lifestyle Interventions and Independence for Elders Pilot (LIFE-P): 2-Year Follow-up. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 64A:4, 462-467
    CrossRef

  14. 14

    P. O. Hendry, J. Hausel, J. Nygren, K. Lassen, C. H. C. Dejong, O. Ljungqvist, K. C. H. Fearon, . (2009) Determinants of outcome after colorectal resection within an enhanced recovery programme. British Journal of Surgery 96:2, 197-205
    CrossRef

  15. 15

    Roland Rau, Eugeny Soroko, Domantas Jasilionis, James W. Vaupel. (2008) Continued Reductions in Mortality at Advanced Ages. Population and Development Review 34:4, 747-768
    CrossRef

  16. 16

    Miriam Segal, Ann Louise Pedersen, Katherine Freeman, Avital Fast. (2008) Medicareʼs New Restrictions on Rehabilitation Admissions. American Journal of Physical Medicine & Rehabilitation 87:11, 872-882
    CrossRef

  17. 17

    Hannah Wunsch, Derek C. Angus, David A. Harrison, Olivier Collange, Robert Fowler, Eric A. J. Hoste, Nicolette F. de Keizer, Alexander Kersten, Walter T. Linde-Zwirble, Alberto Sandiumenge, Kathryn M. Rowan. (2008) Variation in critical care services across North America and Western Europe*. Critical Care Medicine 36:10, 2787-e8
    CrossRef

  18. 18

    Cassio M. Turra, Irma T. Elo. (2008) The Impact of Salmon Bias on the Hispanic Mortality Advantage: New Evidence from Social Security Data. Population Research and Policy Review 27:5, 515-530
    CrossRef

  19. 19

    W. J. Rejeski, A. C. King, J. A. Katula, S. Kritchevsky, M. E. Miller, M. P. Walkup, N. W. Glynn, M. Pahor, . (2008) Physical Activity in Prefrail Older Adults: Confidence and Satisfaction Related to Physical Function. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences 63:1, P19-P26
    CrossRef

  20. 20

    Ahmed M. Abou-Zamzam, Nephtali R. Gomez, Afshin Molkara, Jim E. Banta, Theodore H. Teruya, J. David Killeen, Christian Bianchi. (2007) A Prospective Analysis of Critical Limb Ischemia: Factors Leading to Major Primary Amputation versus Revascularization. Annals of Vascular Surgery 21:4, 458-463
    CrossRef

  21. 21

    Erik Debing, Pierre Van den Brande. (2007) Carotid endarterectomy in the elderly: are the patient characteristics, the early outcome, and the predictors the same as those in younger patients?. Surgical Neurology 67:5, 467-471
    CrossRef

  22. 22

    Jean-Pierre Bacchetta, Enikö Kövari, Marco Merlo, Alessandra Canuto, François R. Herrmann, Constantin Bouras, Gabriel Gold, Patrick R. Hof, Panteleimon Giannakopoulos. (2007) Validation of clinical criteria for possible vascular dementia in the oldest-old. Neurobiology of Aging 28:4, 579-585
    CrossRef

  23. 23

    Alan Maynard. (2006) Medical Workforce Planning: Some Forecasting Challenges. The Australian Economic Review 39:3, 323-329
    CrossRef

  24. 24

    Salah-Eddine Hassani, Roswitha M. Wolfram, Pramod K. Kuchulakanti, Zhenyi Xue, Natalie Gevorkian, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Neil J. Weissman, Ron Waksman,. (2006) Percutaneous coronary intervention with drug-eluting stents in octogenarians: Characteristics, clinical presentation, and outcomes. Catheterization and Cardiovascular Interventions 68:1, 36-43
    CrossRef

  25. 25

    M. Pahor. (2006) Randomized Controlled Trials Involving Multidisciplinary Interventions in the Community. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 61:5, 472-473
    CrossRef

  26. 26

    France Mesle, Jacques Vallin. (2006) Diverging Trends in Female Old-Age Mortality: The United States and the Netherlands versus France and Japan. Population and Development Review 32:1, 123-145
    CrossRef

  27. 27

    D. R. Berk, H. B. Hubert, J. F. Fries. (2006) Associations of Changes in Exercise Level With Subsequent Disability Among Seniors: A 16-Year Longitudinal Study. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 61:1, 97-102
    CrossRef

  28. 28

    Kenneth G. Manton. 2005. Chronic Disease Models. .
    CrossRef

  29. 29

    Kuan-Lang Lai, Rong-Jye Tzeng, Bing-Long Wang, Hong-Shen Lee, Roger L. Amidon, Senyeong Kao. (2005) Health-related quality of life and health utility for the institutional elderly in Taiwan. Quality of Life Research 14:4, 1169-1180
    CrossRef

  30. 30

    Mary Beth Hamel, William G. Henderson, Shukri F. Khuri, Jennifer Daley. (2005) Surgical Outcomes for Patients Aged 80 and Older: Morbidity and Mortality from Major Noncardiac Surgery. Journal of the American Geriatrics Society 53:3, 424-429
    CrossRef

  31. 31

    James H. Rimmer. (2005) Exercise and physical activity in persons aging with a physical disability. Physical Medicine and Rehabilitation Clinics of North America 16:1, 41-56
    CrossRef

  32. 32

    Marianna Noale, Nadia Minicuci, Carola Bardage, Jacob Gindin, Suvi Nikula, Saskia Pluijm, Angel Rodríguez-Laso, Stefania Maggi, for the CLESA working group. (2005) Predictors of mortality: an international comparison of socio-demographic and health characteristics from six longitudinal studies on aging: the CLESA project. Experimental Gerontology 40:1-2, 89-99
    CrossRef

  33. 33

    R CHIESA, G MELISSANO, R CASTELLANO, S FRIGERIO, B CATENACCIO. (2004) Carotid Endarterectomy: Experience in 5425 Cases. Annals of Vascular Surgery 18:5, 527-534
    CrossRef

  34. 34

    Yasuhisa Takeda, Ichiro Kawachi, Zentaro Yamagata, Shuji Hashimoto, Yasuhiro Matsumura, Shigenori Oguri, Akira Okayama. (2004) Multigenerational family structure in Japanese society: impacts on stress and health behaviors among women and men. Social Science & Medicine 59:1, 69-81
    CrossRef

  35. 35

    Gabriela M. Kuster, Matthias E. Pfisterer. (2004) Care of Elderly Patients With Chronic Symptomatic Coronary Artery Disease: Is It TIME to Be More Offensive?. Progress in Cardiovascular Nursing 19:3, 85-89
    CrossRef

  36. 36

    V. Mor, T. T. Perls. (2004) : Measuring Functional Decline in Population Aging in a Changing World and an Evolving Biology. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 59:6, M609-M611
    CrossRef

  37. 37

    Rachana Singh, Samuel Hellman, Ruth Heimann. (2004) The natural history of breast carcinoma in the elderly. Cancer 100:9, 1807-1813
    CrossRef

  38. 38

    D. F. Terry, M. A. Wilcox, M. A. McCormick, T. T. Perls. (2004) Cardiovascular Disease Delay in Centenarian Offspring. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 59:4, M385-M389
    CrossRef

  39. 39

    PETER A. NOSEWORTHY, ILAN LASHEVSKY, PAUL DORIAN, MARY GREENE, SUZAN CVITKOVIC, DAVID NEWMAN. (2004) Feasibility of Implantable Cardioverter Defibrillator Use in Elderly Patients:. Pacing and Clinical Electrophysiology 27:3, 373-378
    CrossRef

  40. 40

    Kaled M. Alektiar, Ennapadam Venkatraman, Nadeem Abu-Rustum, Richard R. Barakat. (2003) Is endometrial carcinoma intrinsically more aggressive in elderly patients?. Cancer 98:11, 2368-2377
    CrossRef

  41. 41

    Helena Korpelainen. (2003) Human life histories and the demographic transition: A case study from Finland, 1870-1949. American Journal of Physical Anthropology 120:4, 384-390
    CrossRef

  42. 42

    Friedemann Honecker, Claus-Henning K??hne, Carsten Bokemeyer. (2003) Colorectal Cancer in the Elderly. Drugs & Aging 20:1, 1-11
    CrossRef

  43. 43

    Igal Teplitsky, Abid Assali, Gregory Golovchiner, Nurit Shor, Avraham Weiss, Alexander Battler, Ran Kornowski. (2003) Acute and intermediate‐term results of percutaneous coronary stenting in octogenarian patients. Acute Cardiac Care 5:4, 195-199
    CrossRef

  44. 44

    Tania Singer, Paul Verhaeghen, Paolo Ghisletta, Ulman Lindenberger, Paul B. Baltes. (2003) The fate of cognition in very old age: Six-year longitudinal findings in the Berlin Aging Study (BASE).. Psychology and Aging 18:2, 318-331
    CrossRef

  45. 45

    Carl M. Kjellstrand, Christopher R. Blagg. (2003) Differences in Dialysis Practice Are the Main Reasons for the High Mortality Rate in the United States Compared to Japan. Hemodialysis International 7:1, 67-71
    CrossRef

  46. 46

    W. L. Adams, H. E. McIlvain, N. L. Lacy, H. Magsi, B. F. Crabtree, S. K. Yenny, M. A. Sitorius. (2002) Primary Care for Elderly People: Why Do Doctors Find It So Hard?. The Gerontologist 42:6, 835-842
    CrossRef

  47. 47

    Hilke Brockmann. (2002) Why is less money spent on health care for the elderly than for the rest of the population? Health care rationing in German hospitals. Social Science & Medicine 55:4, 593-608
    CrossRef

  48. 48

    THOMAS PERLS. (2002) Genetic and Environmental Influences on Exceptional Longevity and the AGE Nomogram. Annals of the New York Academy of Sciences 959:1, 1-13
    CrossRef

  49. 49

    Thomas Perls, Louis M. Kunkel, Annibale A. Puca. (2002) The Genetics of Exceptional Human Longevity. Journal of the American Geriatrics Society 50:2, 359-368
    CrossRef

  50. 50

    (2001) Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial. The Lancet 358:9286, 951-957
    CrossRef

  51. 51

    Karen Andersen-Ranberg, Marianne Schroll, Bernard Jeune. (2001) Healthy Centenarians Do Not Exist, but Autonomous Centenarians Do: A Population-Based Study of Morbidity Among Danish Centenarians. Journal of the American Geriatrics Society 49:7, 900-908
    CrossRef

  52. 52

    William R. Hazzard. (2001) DEMOGRAPHIC PERISTALSIS. Gastroenterology Clinics of North America 30:2, 297-311
    CrossRef

  53. 53

    I.T. Elo. 2001. Mortality Crossover. , 10065-10068.
    CrossRef

  54. 54

    J.W. Vaupel. 2001. Mortality of the Oldest Old. , 10075-10079.
    CrossRef

  55. 55

    Landis MacKellar, David Horlacher. (2000) Population Ageing in Japan: A Brief Survey. Innovation: The European Journal of Social Science Research 13:4, 413-430
    CrossRef

  56. 56

    T. A. Waidmann, K. Liu. (2000) Disability Trends Among Elderly Persons and Implications for the Future. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences 55:5, S298-S307
    CrossRef

  57. 57

    Wayne B Batchelor, Kevin J Anstrom, Lawrence H Muhlbaier, Ralph Grosswald, William S Weintraub, William W O’Neill, Eric D Peterson. (2000) Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: Results in 7,472 octogenarians. Journal of the American College of Cardiology 36:3, 723-730
    CrossRef

  58. 58

    KAZUMI SUEMATSU, MINORU KOHNO. (1999) Age Invariant of Gompertz Function and Exponential Decay of Populations Commensuration with CLOV Experiments. Journal of Theoretical Biology 201:4, 231-238
    CrossRef

  59. 59

    Nortin M. Hadler. (1999) Laboring for Longevity. Journal of Occupational and Environmental Medicine 41:8, 617-621
    CrossRef

  60. 60

    B Experton. (1999) How does managed care manage the frail elderly? The case of hospital readmissions in fee-for-service versus HMO systems. American Journal of Preventive Medicine 16:3, 163-172
    CrossRef

  61. 61

    Ronald Lee, Jonathan Skinner. (1999) Will Aging Baby Boomers Bust the Federal Budget?. Journal of Economic Perspectives 13:1, 117-140
    CrossRef

  62. 62

    R.A. Humble, D.G. Ryan. (1998) Continuing Care Retirement Communities — Attractive to Members, But What About Sponsors?. British Actuarial Journal 4:03, 547-614
    CrossRef

  63. 63

    Michael O. Koch, David A. Miller, Raymond Butler, Leo Lebos, David Collings, Joseph A. Smith. (1998) Are we selecting the right patients for treatment of localized prostate cancer? Results of an actuarial analysis. Urology 51:2, 197-202
    CrossRef

  64. 64

    NEIL J. NUSBAUM. (1998) The Aging/Cancer Connection. The American Journal of the Medical Sciences 315:1, 40-49
    CrossRef

  65. 65

    Graham P Mulley. (1997) Myths of ageing. The Lancet 350:9085, 1160-1161
    CrossRef

  66. 66

    (1996) Forestier's Disease. Journal of Neurosurgery 85:3,
    CrossRef

  67. 67

    Butler, Robert N., . (1996) On Behalf of Older Women — Another Reason to Protect Medicare and Medicaid. New England Journal of Medicine 334:12, 794-796
    Full Text

  68. 68

    (1996) Survival after Age 80. New England Journal of Medicine 334:8, 537-538
    Full Text

  69. 69

    Campion, Edward W., . (1995) New Hope for Home Care?. New England Journal of Medicine 333:18, 1213-1214
    Full Text

Letters